デフォルト表紙
市場調査レポート
商品コード
1620807

放射線治療の世界市場:製品タイプ、用途、エンドユーザー別-2025-2030年予測

Radiotherapy Market by Product (Hardware, Software & Service), Type (External Beam Radiotherapy/Teletherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), Application, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
放射線治療の世界市場:製品タイプ、用途、エンドユーザー別-2025-2030年予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

放射線治療市場は、2023年に65億7,000万米ドルと評価され、2024年には68億9,000万米ドルに達すると予測され、CAGR 5.23%で成長し、2030年には94億米ドルになると予測されています。

放射線治療は、高エネルギーの放射線を利用して、がん細胞のDNAに損傷を与え、その増殖を抑制することにより、がんなどを治療する医療技術です。その必要性は、周囲の健康な組織を温存しながら特定の腫瘍を標的にする有効性から生じ、腫瘍学治療プロトコルの不可欠な一部となっています。放射線治療の用途は、前立腺がん、乳がん、肺がん、脳腫瘍など様々ながんの治療に及ぶ。最終用途は主に病院、がん治療センター、研究機関です。市場成長の原動力は、がん罹患率の増加、体幹部定位放射線治療のような技術の進歩、ヘルスケアインフラに資金を供給する政府の支援政策です。画像誘導や強度変調といった最近の技術革新は、精密医療や個別化治療の選択肢に投資する業界利害関係者に潜在的な機会を提供しています。しかし、高額な機器コストや熟練オペレーターの必要性など、一定の制約は存在し、特に新興国市場における市場開拓を制約する可能性があります。さらに、厳しい規制の枠組みや副作用のリスクがさらなる課題となっています。人工知能を統合して治療の精度と患者の転帰を向上させる研究と技術革新には有望な道があります。さらに、遠隔医療機能の拡大は、アフターケアとモニタリングに革命をもたらすかもしれないです。こうした進歩にもかかわらず、市場参入企業は、進化する規制や、さまざまな社会経済的集団が幅広くアクセスできるようにするための費用対効果の高いソリューションの必要性に警戒し続けなければならないです。全体として、放射線治療市場はダイナミックな成長軌道を描いており、包括的ながん医療に焦点を当てた技術的進歩や戦略的提携によって大きな可能性を秘めています。成長を目指す組織は、市場機会を最大化するために、画期的な技術への投資と、十分に普及していない地域や集団におけるアクセスの拡大という2つの戦略を採用すべきです。

主な市場の統計
基準年[2023] 65億7,000万米ドル
推定年[2024] 68億9,000万米ドル
予測年[2030] 94億米ドル
CAGR(%) 5.23%

市場力学:急速に進化する放射線治療市場の主要市場インサイトを公開

放射線治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • がん治療における放射線治療処置の採用拡大
    • 低侵襲治療への嗜好の高まり
    • 放射線治療に対する政府の取り組みとプログラムの増加
  • 市場抑制要因
    • 高い治療費と訓練を受けた専門家の不足
  • 市場機会
    • 小児がん治療用の高度な放射線治療機器の開発
    • がん治療用ロボット放射線治療システムのイントロダクション
  • 市場の課題
    • 放射線被曝に伴うリスク

ポーターのファイブフォース:放射線治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:放射線治療市場における外部からの影響の把握

外部マクロ環境要因は、放射線治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析放射線治療市場における競合情勢の把握

放射線治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス放射線治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、放射線治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨放射線治療市場における成功への道筋を描く

放射線治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • がん治療における放射線治療手順の採用増加
      • 低侵襲手術への関心の高まり
      • 放射線治療に関する政府の取り組みとプログラムの増加
    • 抑制要因
      • 治療費が高く、訓練を受けた専門家が不足している
    • 機会
      • 小児腫瘍学のための先進的な放射線治療機器の開発
      • がん治療用ロボットシステムのイントロダクション
    • 課題
      • 放射線被曝に伴うリスク
  • 市場セグメンテーション分析
    • 製品:腫瘍部位に高線量の放射線を照射するハードウェア製造プロセスの進歩
    • タイプ:外部から腫瘍を標的とし、大きな腫瘍を標的とする外部放射線治療/遠隔治療に対する消費者の好み
    • 手順:外部ビームの進歩により、プロセスの合理化と患者の快適性の向上が促進される
    • 応用:婦人科がんに対する放射線治療の応用拡大
    • エンドユーザー:がん患者に包括的なケアを提供する病院サービスにおける放射線治療の重要な役割
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 放射線治療市場:製品別

  • ハードウェア
  • ソフトウェアとサービス

第7章 放射線治療市場:タイプ別

  • 外部放射線治療/遠隔治療
    • 従来のCabalt-60遠隔治療ユニット
    • 線形加速器
      • 従来の線形加速器
      • サイバーナイフトモセラピー
      • ガンマナイフ
      • MRIリニアック
      • 定位的先進電子/コバルト60線形加速器
    • 粒子線治療システム
      • サイクロトロン
      • シンクロサイクロトロン
      • シンクロトロン
  • 内部照射放射線治療/近接放射線治療
    • アフターローダー
    • アプリケーター
    • IORTシステム
    • 種子
  • 体系的な放射線治療
    • ロベングアネ(l-131)
    • レニウム186
    • サマリウム153

第8章 放射線治療市場:用途別

  • 乳がん
  • 子宮頸がん
  • 大腸がん
  • 頭頸部がん
  • 肺がん
  • 前立腺がん

第9章 放射線治療市場:エンドユーザー別

  • 病院
  • 独立した放射線治療センター
  • 調査機関

第10章 南北アメリカの放射線治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の放射線治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの放射線治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • GlyTherixとSHINE Technologiesが提携し、Lu-177を使用した悪性がんに対する標的治療を強化
    • GEヘルスケアとエレクタの戦略的提携は、高度なAI統合による放射線治療の強化を目指している
    • ブリストル・マイヤーズスクイブ、レイズバイオ買収で腫瘍学のパイプラインを強化
    • CIVCO放射線治療とQfixがCQメディカルブランドを立ち上げ
    • GEヘルスケア、エレクタと提携しインドにおける精密放射線治療ソリューションへのアクセスを拡大
    • IBAが最新の放射線治療品質保証サービスを開始
  • 戦略分析と提言
    • シーメンスAG

企業一覧

  • Accuray Incorporated
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Charles River Laboratories International, Inc.
  • Elekta AB
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • IBA Dosimetry GmbH
  • IntraOp Medical, Inc.
  • Koninklijke Philips N.V.
  • Leo Cancer Care
  • Mevion Medical Systems
  • Panacea Medical Technologies Pvt. Ltd.
  • PerkinElmer, Inc.
  • Qfix
  • Quanterix Corporation
  • Radiology Oncology Systems
  • Siemens AG
  • ZEISS Group
図表

LIST OF FIGURES

  • FIGURE 1. RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. RADIOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RADIOTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RADIOTHERAPY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RADIOTHERAPY MARKET SIZE, BY SOFTWARE & SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL CABALT-60 TELETHERAPY UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE TOMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RADIOTHERAPY MARKET SIZE, BY MRI LINAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RADIOTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOBENGUANE (L-131), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL RADIOTHERAPY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. EGYPT RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. FINLAND RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. FRANCE RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. GERMANY RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 284. ISRAEL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. ISRAEL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 293. ITALY RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. ITALY RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 302. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. NETHERLANDS RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 311. NIGERIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. NIGERIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 320. NORWAY RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. NORWAY RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 327. POLAND RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 329. POLAND RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. POLAND RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 336. QATAR RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 338. QATAR RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 339. QATAR RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 345. RUSSIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 347. RUSSIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. RUSSIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA RADIOTHERAPY MARKET SIZE,
目次
Product Code: MRR-42653751E6AE

The Radiotherapy Market was valued at USD 6.57 billion in 2023, expected to reach USD 6.89 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 9.40 billion by 2030.

Radiotherapy is a medical technique that utilizes high-energy radiation to treat cancer and other conditions by damaging the DNA of cancerous cells, thereby inhibiting their growth. Its necessity arises from its effectiveness in targeting specific tumors while sparing surrounding healthy tissue, making it an integral part of oncology treatment protocols. Applications of radiotherapy extend to treating various types of cancers, including prostate, breast, lung, and brain tumors. End-use scope primarily encompasses hospitals, cancer treatment centers, and research institutions. Market growth is driven by the increasing prevalence of cancer, advancements in technology like stereotactic body radiation therapy, and supportive government policies financing healthcare infrastructure. Recent innovations such as Image-guided and intensity-modulated radiotherapy offer potential opportunities for industry stakeholders to invest in precision medicine and personalized treatment options. However, certain limitations exist, including high equipment costs and a need for skilled operators, which may constrain market expansion, particularly in developing regions. Moreover, stringent regulatory frameworks and the risk of side effects present additional challenges. There is a promising avenue for research and innovation in integrating artificial intelligence to enhance treatment precision and patient outcomes. Additionally, expanding telemedicine capabilities might revolutionize aftercare and monitoring. Despite these advances, market participants must remain vigilant about evolving regulations and the need for cost-effective solutions to ensure broad access across different socio-economic populations. Overall, the radiotherapy market exhibits a dynamic growth trajectory with significant potential hinging on technological advancements and strategic alliances focused on comprehensive cancer care. Organizations aiming for growth should adopt a dual strategy of groundbreaking technology investments and broadening access in underrepresented regions and populations to maximize market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 6.57 billion
Estimated Year [2024] USD 6.89 billion
Forecast Year [2030] USD 9.40 billion
CAGR (%) 5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radiotherapy Market

The Radiotherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of radiotherapy procedures for cancer treatment
    • Rising preference for minimally invasive procedures
    • Increasing government initiatives and programs for radiotherapy
  • Market Restraints
    • High treatment costs and limited availability of trained professionals
  • Market Opportunities
    • Development of advanced radiotherapy equipment for pediatric oncology
    • Introduction of robotic radiotherapy systems for cancer treatment
  • Market Challenges
    • Risks associated with radiation exposure

Porter's Five Forces: A Strategic Tool for Navigating the Radiotherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radiotherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radiotherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radiotherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radiotherapy Market

A detailed market share analysis in the Radiotherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radiotherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radiotherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Radiotherapy Market

A strategic analysis of the Radiotherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Charles River Laboratories International, Inc., Elekta AB, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., IBA Dosimetry GmbH, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., PerkinElmer, Inc., Qfix, Quanterix Corporation, Radiology Oncology Systems, Siemens AG, and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Hardware and Software & Service.
  • Based on Type, market is studied across External Beam Radiotherapy/Teletherapy, Internal Beam Radiotherapy/Brachytherapy, and Systemic Radiotherapy. The External Beam Radiotherapy/Teletherapy is further studied across Conventional Cabalt-60 Teletherapy Units, Linear Accelerators, and Particle Therapy Systems. The Linear Accelerators is further studied across Conventional Linear Accelerators, CyberKnife TomoTherapy, Gamma Knife, MRI LINAC, and Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators. The Particle Therapy Systems is further studied across Cyclotrons, Synchrocyclotron, and Synchrotrons. The Internal Beam Radiotherapy/Brachytherapy is further studied across Afterloaders, Applicators, IORT Systems, and Seeds. The Systemic Radiotherapy is further studied across lobenguane (l-131), Rhenium-186, and Samarium-153.
  • Based on Application, market is studied across Breast Cancer, Cervical Cancer, Colorectal Cancer, Head & Neck Cancer, Lung Cancer, and Prostate Cancer.
  • Based on End-User, market is studied across Hospitals, Independent Radiotherapy Centers, and Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of radiotherapy procedures for cancer treatment
      • 5.1.1.2. Rising preference for minimally invasive procedures
      • 5.1.1.3. Increasing government initiatives and programs for radiotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment costs and limited availability of trained professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced radiotherapy equipment for pediatric oncology
      • 5.1.3.2. Introduction of robotic radiotherapy systems for cancer treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with radiation exposure
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Advancements in hardware manufacturing process as it provide high radiation doses to the tumor site
    • 5.2.2. Type: Consumer preference for external beam radiotherapy/teletherapy as they target tumor from outside and large tumors
    • 5.2.3. Procedure: Increasing advancements in external beam radiotherapy to streamline process and improve patient comfort
    • 5.2.4. Application: Growing application of radiotherapy for gynecological cancer
    • 5.2.5. End-User: Significant role of radiotherapy for hospitals service as they provide comprehensive care for cancer patients
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Radiotherapy Market, by Product

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software & Service

7. Radiotherapy Market, by Type

  • 7.1. Introduction
  • 7.2. External Beam Radiotherapy/Teletherapy
    • 7.2.1. Conventional Cabalt-60 Teletherapy Units
    • 7.2.2. Linear Accelerators
      • 7.2.2.1. Conventional Linear Accelerators
      • 7.2.2.2. CyberKnife TomoTherapy
      • 7.2.2.3. Gamma Knife
      • 7.2.2.4. MRI LINAC
      • 7.2.2.5. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
    • 7.2.3. Particle Therapy Systems
      • 7.2.3.1. Cyclotrons
      • 7.2.3.2. Synchrocyclotron
      • 7.2.3.3. Synchrotrons
  • 7.3. Internal Beam Radiotherapy/Brachytherapy
    • 7.3.1. Afterloaders
    • 7.3.2. Applicators
    • 7.3.3. IORT Systems
    • 7.3.4. Seeds
  • 7.4. Systemic Radiotherapy
    • 7.4.1. lobenguane (l-131)
    • 7.4.2. Rhenium-186
    • 7.4.3. Samarium-153

8. Radiotherapy Market, by Application

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Cervical Cancer
  • 8.4. Colorectal Cancer
  • 8.5. Head & Neck Cancer
  • 8.6. Lung Cancer
  • 8.7. Prostate Cancer

9. Radiotherapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Independent Radiotherapy Centers
  • 9.4. Research Organizations

10. Americas Radiotherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Radiotherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. GlyTherix and SHINE Technologies partner to enhance targeted radiotherapy treatments for aggressive cancers using Lu-177
    • 13.3.2. GE Healthcare and Elekta's strategic alliance aims to enhance radiation therapy with advanced AI integration
    • 13.3.3. Bristol Myers Squibb strengthens oncology pipeline with RayzeBio acquisition
    • 13.3.4. CIVCO Radiotherapy and Qfix Launch CQ Medical Brand
    • 13.3.5. GE HealthCare Collaborates with Elekta to Expand Access to Precision Radiation Therapy Solutions in India
    • 13.3.6. IBA Launches Latest Radiation Therapy Quality Assurance Offerings
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Siemens AG

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Agilent Technologies Inc.
  • 3. Becton, Dickinson and Company
  • 4. Cardinal Health, Inc.
  • 5. Charles River Laboratories International, Inc.
  • 6. Elekta AB
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. GE HealthCare Technologies Inc.
  • 9. IBA Dosimetry GmbH
  • 10. IntraOp Medical, Inc.
  • 11. Koninklijke Philips N.V.
  • 12. Leo Cancer Care
  • 13. Mevion Medical Systems
  • 14. Panacea Medical Technologies Pvt. Ltd.
  • 15. PerkinElmer, Inc.
  • 16. Qfix
  • 17. Quanterix Corporation
  • 18. Radiology Oncology Systems
  • 19. Siemens AG
  • 20. ZEISS Group